» Articles » PMID: 28746031

Incidence of Biliary Atresia and Timing of Hepatoportoenterostomy in the United States

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2017 Jul 27
PMID 28746031
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the incidence, trends, seasonality, and age at the time of hepatoportoenterostomy (Kasai procedure) for biliary atresia in the US.

Study Design: The triennial Health Cost and Utilization Project-Kids' Inpatient Database for 1997-2012 was used to perform a retrospective analysis of biliary atresia in the US. Infants aged <1 year of age with a diagnosis of biliary atresia who underwent a Kasai procedure were included. Nationwide infant population data were used to calculate incidence and evaluate trends. Age at the time of the Kasai procedure and the seasonality of biliary atresia were evaluated as well.

Results: The incidence of biliary atresia in the US was 4.47 per 100 000 and was higher in females (risk ratio [RR], 1.43; 95% CI, 1.27-1.62), Asian/Pacific Islanders (RR, 1.89; 95% CI, 1.44-2.47), and blacks (RR, 1.30; 95% CI, 1.06-1.58) compared with whites. The incidence of biliary atresia increased by an average of 7.9% per year from 1997 to 2012 (P <.001). The median age at the time of the Kasai procedure was 63 days, with no improvement over the study period (P = .64). There was no evidence of seasonality (P = .69).

Conclusion: The incidence of biliary atresia has increased over the past 15 years, with the median age at the time of the Kasai procedure now outside the optimal window. Implementation of systematic screening measures for biliary atresia in the US are needed.

Citing Articles

Development of an artificial intelligence-based multimodal diagnostic system for early detection of biliary atresia.

Ma Y, Yang Y, Du Y, Jin L, Liang B, Zhang Y BMC Med. 2025; 23(1):127.

PMID: 40016769 PMC: 11866655. DOI: 10.1186/s12916-025-03962-x.


Microcystin-RR is a biliary toxin selective for neonatal extrahepatic cholangiocytes.

Gupta K, Chen D, Wells R JHEP Rep. 2024; 7(1):101218.

PMID: 39687604 PMC: 11648759. DOI: 10.1016/j.jhepr.2024.101218.


The Assessment and Management of Biliary Atresia in Hawai'i, 2009-2023.

Singh S, Balaraman K, Johnson M, Balaraman V, Puapong D, Johnson S Hawaii J Health Soc Welf. 2024; 83(10):268-273.

PMID: 39371585 PMC: 11450321. DOI: 10.62547/NUOX8943.


Incidence and outcome of biliary atresia in Shanghai, China from 2015 to 2016: a cohort study.

Yang Y, Dong R, Chen G, Zheng S, Yan W, Shen Z BMJ Paediatr Open. 2024; 8(1).

PMID: 39284614 PMC: 11409342. DOI: 10.1136/bmjpo-2023-002475.


Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis.

Hari Gopal S, Zebda R, Mohan A, Borovsky K, Takwoingi Y, Scandrett K PLoS One. 2024; 19(8):e0307837.

PMID: 39197055 PMC: 11357077. DOI: 10.1371/journal.pone.0307837.